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Discussion&and&Conclusions&( The(results(indicated(that(Cannabidiol(did(not(have(a(significant(effect(in(preventing(sensitization(induction(from(MK:801(maleate(in(mice.(In(fact,(sensitization(induction(appears(not(to(have(occurred,(since(there(was(no(significant(increase(in(the(SAL:MK801(group(from(the(Induction(Trial(to(the(Sensitization(Trial((Figure(6).(Clearly(this(suggests(that(the(two:dose(method(of(inducing(sensitization(to(MK:801(is(insufficient(and(should(be(altered(to(at(least(4(chronic(doses(of(MK:801(similar(to(the(study(by(Carey(and(colleagues((1995).((( Other(possibilities(for(a(lack(of(significance(include(length(of(induction(period,(dose,(stereotypy,(lack(of(baseline(activity(level,(individual(mouse(variability,(novel(environment,(and(sample(size(per(group.(( The(induction(period(consisted(of(only(one(dose(administered(72(hours(before(challenge(dose(testing.(Although(it(was(shown(that(a(single(high(dose(could(induce(sensitization,(it(is(possible(that(the(0.5(mg/kg(dose(was(not(high(enough((Hargreaves(and(Cain,(1995).(However,(the(reason(this(dose(was(used(instead(of(a(higher(dose(was(to(prevent(stereotypy,(because(locomotor(activity(was(used(as(a(measurement(of(drug(effects.(Unfortunately(stereotypy(was(still(present,(which(may(have(also(affected(the(activity(scores.(However,(it(is(also(possible(that(72(hours(was(too(long(a(washout(period.(Returning(to(Wise((2002),(it(is(possible(that(although(sensitization(lasts(a(“very(long(time”,(it(had(already(decreased(by(72(hours(post(pretreatment.(Due(to(this(factor,(the(wash(out(period(is(suggested(to(decrease(to(48(hours.(( The(dose(of(cannabidiol(also(could(have(been(much(too(low((1.0(mg/kg).(Perhaps(it(should(be(double(the(dose(for(future(experiments(to(guarantee(effects.(In(a(study(by(
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